Dudediligence.

CervoMed Inc

CRVONASDAQ · Pharmaceutical Preparations
Write an idea

Fundamentals

Oldest to newest
Revenue, by quarter
$1.9MSep ’24$2.2MDec ’24$1.9MMar ’25$1.8MJun ’25$322,569Sep ’25$8,726Dec ’25$0.00Mar ’26$0.00Jun ’26
Net income, by quarter
−$4.8MSep ’24−$6.7MDec ’24−$4.9MMar ’25−$6.3MJun ’25−$7.7MSep ’25−$8.1MDec ’25−$8.0MMar ’26−$6.6MJun ’26
Fiscal years, by the month each ended
LineDec 2021Dec 2022Dec 2023Dec 2024Dec 2025
Revenuenone on file$0.00$7.1M$9.7M$4.0M
Operating income−$24.7M−$3.5M−$7.8M−$18.2M−$28.3M
Net income−$24.1M−$5.8M−$2.2M−$16.3M−$27.0M
Operating cash flow−$14.5M−$2.6M−$7.4M−$16.5M−$23.4M
Cash$37.3M$4.1M$7.8M$9.0M$8.2M
Shares outstanding2.0M518.1K5.7M8.7M9.3M